145 related articles for article (PubMed ID: 22819798)
21. Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.
Kobayashi J; Torigoe T; Hirohashi Y; Idenoue S; Miyazaki A; Yamaguchi A; Hiratsuka H; Sato N
J Transl Med; 2009 Jan; 7():1. PubMed ID: 19123955
[TBL] [Abstract][Full Text] [Related]
22. Novel epitopes identified from Mycobacterium tuberculosis antigen Rv2629induces cytotoxic T lymphocyte response.
Bai X; Wang D; Liu Y; Xiao L; Liang Y; Yang Y; Zhang J; Lin M; Wu X
Immunol Lett; 2018 Nov; 203():21-28. PubMed ID: 29908955
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis.
Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J
Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013
[TBL] [Abstract][Full Text] [Related]
24. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
Lewinsohn DM; Zhu L; Madison VJ; Dillon DC; Fling SP; Reed SG; Grabstein KH; Alderson MR
J Immunol; 2001 Jan; 166(1):439-46. PubMed ID: 11123322
[TBL] [Abstract][Full Text] [Related]
25. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
[TBL] [Abstract][Full Text] [Related]
26. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
Oiso M; Eura M; Katsura F; Takiguchi M; Sobao Y; Masuyama K; Nakashima M; Itoh K; Ishikawa T
Int J Cancer; 1999 May; 81(3):387-94. PubMed ID: 10209953
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel T cell epitopes from efflux pumps of Mycobacterium tuberculosis.
Zhu YH; Gao YF; Chen F; Liu W; Zhai MX; Zhai WJ; Qi YM; Ye Y
Immunol Lett; 2011 Oct; 140(1-2):68-73. PubMed ID: 21756938
[TBL] [Abstract][Full Text] [Related]
28. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
[TBL] [Abstract][Full Text] [Related]
29. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte.
Nukaya I; Yasumoto M; Iwasaki T; Ideno M; Sette A; Celis E; Takesako K; Kato I
Int J Cancer; 1999 Jan; 80(1):92-7. PubMed ID: 9935237
[TBL] [Abstract][Full Text] [Related]
30. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
[TBL] [Abstract][Full Text] [Related]
31. Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in
Ramaiah A; Nayak S; Rakshit S; Manson AL; Abeel T; Shanmugam S; Sahoo PN; John AJUK; Sundaramurthi JC; Narayanan S; D'Souza G; von Hoegen P; Ottenhoff THM; Swaminathan S; Earl AM; Vyakarnam A
Front Immunol; 2019; 10():195. PubMed ID: 30814998
[TBL] [Abstract][Full Text] [Related]
32. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.
Tahara K; Takesako K; Sette A; Celis E; Kitano S; Akiyoshi T
Clin Cancer Res; 1999 Aug; 5(8):2236-41. PubMed ID: 10473111
[TBL] [Abstract][Full Text] [Related]
33. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.
Bae J; Hideshima T; Zhang GL; Zhou J; Keskin DB; Munshi NC; Anderson KC
Leukemia; 2018 Mar; 32(3):752-764. PubMed ID: 29089645
[TBL] [Abstract][Full Text] [Related]
35. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.
Kontani K; Teramoto K; Ozaki Y; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Yokomise H; Ohkubo I
Int J Oncol; 2004 Dec; 25(6):1537-42. PubMed ID: 15547688
[TBL] [Abstract][Full Text] [Related]
36. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.
Tully G; Kortsik C; Höhn H; Zehbe I; Hitzler WE; Neukirch C; Freitag K; Kayser K; Maeurer MJ
J Immunol; 2005 Feb; 174(4):2174-84. PubMed ID: 15699149
[TBL] [Abstract][Full Text] [Related]
37. Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.
Caccamo N; Pietra G; Sullivan LC; Brooks AG; Prezzemolo T; La Manna MP; Di Liberto D; Joosten SA; van Meijgaarden KE; Di Carlo P; Titone L; Moretta L; Mingari MC; Ottenhoff TH; Dieli F
Eur J Immunol; 2015 Apr; 45(4):1069-81. PubMed ID: 25631937
[TBL] [Abstract][Full Text] [Related]
38. Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.
Commandeur S; Coppola M; Dijkman K; Friggen AH; van Meijgaarden KE; van den Eeden SJ; Wilson L; van der Ploeg-van Schip JJ; Franken KL; Geluk A; Ottenhoff TH
PLoS One; 2014; 9(6):e99203. PubMed ID: 24905579
[TBL] [Abstract][Full Text] [Related]
39. Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.
Minami T; Minami T; Shimizu N; Yamamoto Y; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H
Int Immunopharmacol; 2014 May; 20(1):59-65. PubMed ID: 24583149
[TBL] [Abstract][Full Text] [Related]
40. Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer.
Sawada Y; Komori H; Tsunoda Y; Shimomura M; Takahashi M; Baba H; Ito M; Saito N; Kuwano H; Endo I; Nishimura Y; Nakatsura T
Oncol Rep; 2014 Mar; 31(3):1051-8. PubMed ID: 24366042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
